Verato, Inc. – Trademark Portfolio

Entity Type: 03

Verato, Inc. holds 47 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 47 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 2 Nice Classification classes. Currently, 20 trademarks are registered and 20 are pending. Notable registered marks include HMDM, UMPI, VERATO, VERATO UMPI, and VERATO VIEW. The owner is based in McLean, VA.

1751 Pinnacle Drive, Suite 1700

McLean, VA 22102

47 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (47 results)

Trademark Classifications

Verato, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (47 filings)

Scientific and technological services; industrial analysis and research services

38
Telecommunications (1 filing)

Telecommunications

Frequently Asked Questions

How many trademarks does Verato, Inc. have?

Verato, Inc. has 47 U.S. trademarks filed with the USPTO. Of these, 20 registered, 20 pending, 2 abandoned, 5 cancelled.

What trademark classes does Verato, Inc. file in?

Verato, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Verato, Inc.'s most well-known trademarks?

Verato, Inc.'s registered trademark portfolio includes well-known marks such as HMDM, UMPI, VERATO, VERATO UMPI, and VERATO VIEW. These are among 20 currently registered trademarks in the portfolio.

What is Verato, Inc.'s trademark registration success rate?

Verato, Inc. has a 74% trademark registration rate, with 20 out of 27 resolved applications resulting in successful registration. Currently, 20 applications are pending review.